TheProfitWatch

CNTX - Context Therapeutics Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.17 -0.1 (-8.32%) 0.0 (0.0%) 0.0 (0.03%) -0.02 (-1.81%) -0.02 (-2.04%) -0.07 (-6.11%) 0.0 (0.0%) -0.02 (-1.41%)

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.09
Diluted EPS:
-0.09
Basic P/E:
-11.8922
Diluted P/E:
-11.8922
RSI(14) 1m:
50.47
VWAP:
1.07
RVol:

Events

Period Kind Movement Occurred At

Related News